1. Home
  2. NEON vs INTS Comparison

NEON vs INTS Comparison

Compare NEON & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neonode Inc.

NEON

Neonode Inc.

BUY

Current Price

$0.89

Market Cap

14.8M

Sector

Technology

ML Signal

BUY

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$3.85

Market Cap

13.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEON
INTS
Founded
1997
2012
Country
Sweden
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
13.7M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
NEON
INTS
Price
$0.89
$3.85
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $19.33
AVG Volume (30 Days)
★ 46.6K
14.1K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.88
N/A
EPS
★ N/A
N/A
Revenue
★ $3,108,000.00
N/A
Revenue This Year
$69.35
N/A
Revenue Next Year
$28.95
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.72
$0.22
52 Week High
$3.81
$8.06

Technical Indicators

Market Signals
Indicator
NEON
INTS
Relative Strength Index (RSI) 54.53 43.17
Support Level $0.83 $0.30
Resistance Level $0.95 $4.30
Average True Range (ATR) 0.06 0.30
MACD 0.00 -0.00
Stochastic Oscillator 61.40 34.86

Price Performance

Historical Comparison
NEON
INTS

About NEON Neonode Inc.

Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: